Similar Papers

Paper Title
Journal
Date
Author
Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison
Talha Munir ... Keri Yang
Blood | VOL. 142
Talha Munir, et. al.Talha Munir ... Keri Yang
28 Nov 2023
Matching-adjusted indirect treatment comparison in patients with radioiodine-refractory differentiated thyroid cancer
Tim Holbrook ... Corey Pelletier
Comparative Effectiveness Research | VOL. 6
Tim Holbrook, et. al.Tim Holbrook ... Corey Pelletier
01 Apr 2016
PCN69 Cost-Effectiveness Analysis of NOVEL Therapies for HER2+ Metastatic Breast Cancer: [FAM-] Trastuzumab Deruxtecan Versus Tucatinib Trastuzumab and Capecitabine Combination
G Vondeling ... W Sullivan
Value in Health | VOL. 23
G Vondeling, et. al.G Vondeling ... W Sullivan
01 Dec 2020
Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics.
Arnaud Bourdin ... Mohd Kashif Siddiqui
Clinical & Experimental Allergy | VOL. 50
Arnaud Bourdin, et. al.Arnaud Bourdin ... Mohd Kashif Siddiqui
20 Mar 2020
View more papers

More From: Value in Health

Paper Title
Journal
Date
Author
Table of Contents
-
Value in Health | VOL. -
--
01 Jan 2025
A Value Set for the EQ-5D-5L for United Arab Emirates
Fatima Al Sayah ... Samer A Kharroubi
Value in Health | VOL. -
Fatima Al Sayah, et. al.Fatima Al Sayah ... Samer A Kharroubi
01 Jan 2025
Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations
Zixuan Jin ... Ka Keat Lim
Value in Health | VOL. -
Zixuan Jin, et. al.Zixuan Jin ... Ka Keat Lim
01 Jan 2025
Development and testing the psychometric properties of 20 bolt-on items for the EQ-5D-5L across 31 rare diseases
Richard Huan Xu ... Shuyang Zhang
Value in Health | VOL. -
Richard Huan Xu, et. al.Richard Huan Xu ... Shuyang Zhang
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.